Loading...
Living Cell Technologies Limited
LCT.AX•ASX
Healthcare
Biotechnology
A$0.01
A$0.001(7.14%)
Living Cell Technologies Limited (LCT.AX) Company Profile & Overview
Explore Living Cell Technologies Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Living Cell Technologies Limited (LCT.AX) Company Profile & Overview
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
SectorHealthcare
IndustryBiotechnology
CEODavid Richard Hainsworth
Contact Information
Company Facts
IPO DateSep 1, 2004
CountryAU